Novartis Health (06606) rose more than 11%. As of press release, it rose 11.19% to HK$17.68, with a turnover of HK$349.31 million.
The Zhitong Finance App learned that Novartis Health (06606) rose by more than 11%. As of press release, it had risen 11.19% to HK$17.68, with a turnover of HK$349.13,000.
According to the news, Novartis Health previously released Yingxi. According to the median financial data before the audit, as of December 31, 2023, the Group's total annual revenue reached RMB 2.01 billion, an increase of 164% over the previous year, an increase of 26 times over 2020, and cash payments exceeded RMB 1.4 billion. The company achieved annual gross profit of RMB 1.84 billion and achieved profit after tax in the first year. According to reports, Chang Weiqing contributed 59% to the Group's total revenue, with more than 1.04 million samples tested, and confirmed revenue of 1.19 billion yuan, an increase of 235% over 2022 confirmed revenue. Furthermore, Youyou Tube and Pop Tube grew higher than the full-year guide, and revenue and gross profit continued to rise.
Southwest Securities pointed out that the company's 2023 performance continued to exceed expectations, and the volume and price of the three major products rose sharply. Zhongtai Securities pointed out that at present, the company's sales, marketing, operation and R&D management systems in the colorectal cancer early screening market have all entered steady development, which is enough to effectively support vertical and horizontal commercial expansion. At the same time, Chang Weiqing's entry and volume in public hospitals has accelerated markedly, laying the foundation for Chang Weiqing's market penetration target of 5% in 2025. In addition, the company continued to strengthen accounts receivable management, and the return of funds was significantly accelerated during the reporting period. It is expected that the repayment amount will continue to increase rapidly in 2024, promoting continuous optimization of the quality of the company's statements and achieving healthy and sustainable growth.